5 completed, 1 recruiting. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Completed 5, Recruiting 1 |
Follow Xintian Pharmaceutical: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Prunella Oral Liquid in the Treatment of Thyroid Nodules regular dose of JiRui® Prunella oral liquid, 2x regular dose of JiRui® Prunella oral liquid, regular dose of placebo - Thyroid Nodule | Phase 4 | Recruiting | Xintian Pharmaceutical | 234 | 2024-07-30 | 2026-03-24 |
| Efficacy and Safety of Ningmitai Capsule Alone or Combined With Celecoxib in the Treatment of CP/CPPS Ningmitai capsule, Celecoxib capsule, Ningmitai placebo - Chronic Prostatitis | Phase 4 | Completed | Xintian Pharmaceutical | 242 | 2023-12-19 | 2026-07-27 |
| The Efficacy and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia Silodosin Capsules, Tamsulosin - Benign Prostatic Hyperplasia With Lower Urinary Tract Symptoms | Phase 4 | Completed | Xintian Pharmaceutical | 110 | 2022-09-21 | 2026-09-09 |
| Clinical Observation of Ningmitai Capsule in Treating Chronic Pelvic Pain Syndrome With Erectile Dysfunction Sildenafil, Ningmitai capsule, Ningbitai capsule + sildenafil - Chronic Prostatitis With Chronic Pelvic Pain Syndrome, Erectile Dysfunction | Phase 4 | Completed | Xintian Pharmaceutical | 254 | 2019-03-19 | 2023-10-12 |
| Efficacy and Safety of Ningmitai Capsule in Patients With Chronic Prostatitis/Chronic Pelvic Pain Syndrome Ningmitai Capsule, Tamsulosin Hydrochloride - Chronic Prostatitis | Phase 4 | Completed | Xintian Pharmaceutical | 323 | 2018-11-16 | 2023-06-06 |
| Clinical Study of Ningmitai Capsule on Promoting the Passage of Residual Fragments After Ureteroscopic Lithotripsy Control group, Ningmitai capsule, Combined group (Ningmitai plus tamsulosin) - Ureteral Calculi | Phase 4 | Completed | Xintian Pharmaceutical | 251 | 2016-10-02 | 2023-10-30 |
Erectile Dysfunction (1) · Prostatitis (1) · Thyroid Nodule (1) · Ureteral Calculi (1)
Tamsulosin (3) · Celecoxib (1) · Control Groups (1) · Diclofenac (1) · Sildenafil Citrate (1) · silodosin (1)
China (5)
Zhongguo Chen, MD (2) · Deng Chunhua, Doctor (1) · Yuan Jingdong, Doctor (1)